Effect of selenium supplementation on glycemic indices: a meta-analysis of randomized controlled trials
The association between selenium supplementation and glycemic indices seems to be a controversial issue. This systematic review and meta-analysis was conducted to evaluate the effect of selenium supplementation on glycemic indices.
We systematically searched PubMed/MEDLINE, ISI/WOS, and Scopus (from their commencements up to Jan 2016) for relevant studies examining the association between intake of selenium and glycemic indices. The data were extracted from relevant qualified studies and estimated using the random-effect or pooled model and standardized mean difference (SMD) with 95% confidence interval (CI).
Twelve articles published between 2004 and 2016 were included. In all the studies, the participants were randomly assigned to an intervention group (n = 757) or a control group(n = 684). All the studies were double blind, placebo controlled trials. Selenium supplementation resulted in a significant decrease in homeostasis model of assessment-estimated β-cell function (HOMA-B) (SMD: -0.63; 95%CI: −0.89 to −0.38) and a significant increase in quantitative insulin sensitivity check index (QUICKI) (SMD: by 0.74; 95%CI: 0.49 to 0.1) as compared with the controls. There were no statistically significant improvements in glycemic indices, such as fasting plasma glucose (FPG), insulin, homeostasis model of assessment-estimated insulin resistance (HOMA-IR), Hemoglobin A1c (HbA1c) and adiponectin.
This meta-analysis indicated that selenium supplementation significantly decreased HOMA-B and increased QUICKI score. There was no statistically significant improvement in FPG, insulin, HOMA-IR, HbA1c and adiponectin indices following selenium supplementation.
KeywordsSelenium Glycemic indices FPG Insulin HbA1c
This study was funded by Alborz University of Medical Sciences. The authors are thankful of Emam Ali clinical research development unit for their assistance.
Compliance with ethical standards
Conflict of interest
- 13.Stranges S, Marshall James R, Raj N, Donahue Richard P, Maurizio T, Combs Gerald F, et al. Effects of long-term selenium supplementation on the incidence of type 2 DiabetesA randomized TrialSelenium supplementation and risk for type 2 diabetes. Ann Intern Med. 2007a;147(4):217–23.CrossRefGoogle Scholar
- 18.Khosravi M, Djalalinia S, Hasani M, Saeedi Moghaddam S, Kazemzadeh Atoofi M, Asayesh H, et al. Effects of selenium supplementation on cardiometabolic risk factors, inflammatory factors and antioxidant factors : a systematic review and meta-analysis protocol. IJPM. 2017; (Submitted).Google Scholar
- 23.Intercooled Stata. 8.0 for windows. College Station, TX: Stata Corp; 2003. 2007.Google Scholar
- 24.Alizadeh M, Safaeiyan A, Ostadrahimi A, Estakhri R, Daneghian S, Ghaffari A, et al. Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial. Ann Nutr Metab. 2012;60(2):157–68.CrossRefGoogle Scholar
- 32.Murer SB, Aeberli I, Braegger CP, Gittermann M, Hersberger M, Leonard SW, et al. Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents. J Nutr. 2014;144(2):193–201.CrossRefGoogle Scholar
- 34.Shargorodsky M, Debby O, Matas Z, Zimlichman R. Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutr Metab (Lond). 2010;7:55.CrossRefGoogle Scholar
- 35.Mohammad Hosseinzadeh F, Hosseinzadeh-Attar MJ, Yekaninejad MS, Rashidi B. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: a randomized, double blinded, placebo controlled clinical trial. J Trace Elem Med Biol. 2016;34:56–61.CrossRefGoogle Scholar
- 38.Vinceti M, Filippini T, Rothman KJ. Selenium exposure and the risk of type 2 diabetes: a systematic review and meta-analysis. Springer. 2018.Google Scholar
- 40.Farrokhian A, Bahmani F, Taghizadeh M, Mirhashemi SM, Aarabi MH, Raygan F, et al. Research metabolic. Selenium supplementation affects insulin resistance and serum hs-CRP in patients with type 2 diabetes and coronary. Heart Dis. 2016b;48(04):263–8.Google Scholar
- 42.Tabrizi R, Maryam A, Mahmood M, Lankarani Kamran B, Taghi HS, Fariba K, et al. The effects of selenium supplementation on glucose metabolism and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Horm Metab Res. 2017;49(11):826–30.CrossRefGoogle Scholar